Disease on EC 1.13.11.27 - 4-hydroxyphenylpyruvate dioxygenase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
4-hydroxyphenylpyruvate dioxygenase deficiency
Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
4-hydroxyphenylpyruvate dioxygenase deficiency
In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
4-hydroxyphenylpyruvate dioxygenase deficiency
Tyrosinemia type III: diagnosis and ten-year follow-up.
4-hydroxyphenylpyruvate dioxygenase deficiency
Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
Adenocarcinoma
Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen.
Airway Obstruction
The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.
Alkaptonuria
A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.
Alkaptonuria
Pyrazolone-quinazolone hybrids: a novel class of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Anemia
Electrostatic Architecture of the Infectious Salmon Anemia Virus (ISAV) Core Fusion Protein Illustrates a Carboxyl-Carboxylate pH Sensor.
Ataxia
Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
Ataxia
In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
Blister
Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin.
Breast Neoplasms
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Bronchiolitis, Viral
Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils.
Bronchopulmonary Dysplasia
Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia.
Carcinogenesis
Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis.
Carcinoma
Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus.
Carcinoma, Hepatocellular
Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
Carcinoma, Hepatocellular
Hepatitis C virus f protein is a short-lived protein associated with the endoplasmic reticulum.
Carcinoma, Hepatocellular
Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG2 cells.
Carcinoma, Hepatocellular
Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis.
Carcinoma, Hepatocellular
Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Carcinoma, Papillary
The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
Cholera
Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.
Cholera
Respiratory syncytial virus recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice.
Coinfection
Characterization of Newcastle disease virus envelope glycoproteins expressed in insect cells.
Corneal Opacity
Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury.
Distemper
Amino-terminal precursor sequence modulates canine distemper virus fusion protein function.
Distemper
Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function.
Distemper
Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity.
Distemper
Immunological relationships between phocid and canine distemper virus studied with monoclonal antibodies.
Distemper
Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35.
Distemper
Interaction of a synthetic peptide corresponding to the N-terminus of canine distemper virus fusion protein with phospholipid vesicles: a biophysical study.
Distemper
Measles virus fusion protein is palmitoylated on transmembrane-intracytoplasmic cysteine residues which participate in cell fusion.
Distemper
Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins.
Distemper
The fusion protein gene of phocine distemper virus: nucleotide and deduced amino acid sequences and a comparison of morbillivirus fusion proteins.
Distemper
The nucleotide and predicted amino acid sequence of the fusion protein of recent isolates of canine distemper virus in Japan.
Distemper
The nucleotide sequence of the gene encoding the F protein of canine distemper virus: a comparison of the deduced amino acid sequence with other paramyxoviruses.
Distemper
Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds.
Eosinophilia
Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
Epidermolysis Bullosa
Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin.
Fanconi Anemia
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
Fanconi Anemia
RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.
Fanconi Anemia
The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
Fibrosarcoma
Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.
Fowlpox
Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10.
Fowlpox
Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.
Graves Disease
Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools.
Heart Defects, Congenital
Respiratory syncytial virus infections in infants affected by primary immunodeficiency.
Hepatitis C
Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Hepatitis C
Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
Hepatitis C
Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.
Hepatitis C
Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection.
Hepatitis C
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.
Hepatitis C
Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
Hepatitis C
Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population.
Hepatitis C
Hepatitis C virus F protein inhibits cell apoptosis by activation of intracellular NF-kappaB pathway.
Hepatitis C
Hepatitis C virus f protein is a short-lived protein associated with the endoplasmic reticulum.
Hepatitis C
Hepatitis C virus F protein sequence reveals a lack of functional constraints and a variable pattern of amino acid substitution.
Hepatitis C
Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG2 cells.
Hepatitis C
Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis.
Hepatitis C
Interaction of hepatitis C virus F protein with prefoldin 2 perturbs tubulin cytoskeleton organization.
Hepatitis C
Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
Hepatitis C
Screening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid system.
Hepatitis C
Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Hepatitis C
Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein.
Hepatitis C
Triple decoding of hepatitis C virus RNA by programmed translational frameshifting.
Hepatitis C
[Antigenicity of hepatitis C virus F protein and serum prevalence of anti-F in HCV-infected patients]
Hepatitis C
[Hepatitis C virus F protein-mediated inhibition of hepatoma cell proliferation].
Hepatitis C
[Influence of F protein of hepatitis C virus subtype 1b inhibits on human hepatocellular carcinom HepG2 cell apoptosis]
Hepatitis C
[Screening and cloning target genes transactivated by hepatitis C virus F protein using suppression subtractive hybridization technique]
Hepatitis C, Chronic
Antigenic relevance of F protein in chronic hepatitis C virus infection.
Hepatitis C, Chronic
Characterization of the specific CD4+ T cell response against the F protein during chronic hepatitis C virus infection.
Hepatitis C, Chronic
F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.
Hepatitis C, Chronic
Hepatitis C virus alternate reading frame protein decreases interferon-? secretion in peripheral blood mononuclear cells.
Hepatitis C, Chronic
Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Hepatitis C, Chronic
[The detection of antibodies to HCV F protein with immune enzyme analysis using synthetic peptide.]
Hypersensitivity
Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
Ichthyosis
Crystallization of the xeroderma pigmentosum group F endonuclease from Aeropyrum pernix.
Infections
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction.
Infections
A conformational epitope on the dimer of the fusion protein of respiratory syncytial virus detected in natural infections.
Infections
Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.
Infections
Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.
Infections
Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection.
Infections
Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice.
Infections
Building a better neonatal mouse model to understand infant respiratory syncytial virus disease.
Infections
Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.
Infections
Characterization of an alternate form of Newcastle disease virus fusion protein.
Infections
Characterization of Newcastle disease virus envelope glycoproteins expressed in insect cells.
Infections
Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
Infections
Characterization of the specific CD4+ T cell response against the F protein during chronic hepatitis C virus infection.
Infections
Characterization of two monoclonal antibodies, 38F10 and 44D11, against the major envelope fusion protein of Helicoverpa armigera nucleopolyhedrovirus.
Infections
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.
Infections
Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.
Infections
Determinants of pantropism of the F1-R mutant of Sendai virus: specific mutations involved are in the F and M genes.
Infections
Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection.
Infections
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.
Infections
Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab.
Infections
Dual functions of a 4-hydroxyphenylpyruvate dioxygenase for Vibrio splendidus survival and infection.
Infections
Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein Containing Virus-like Particles.
Infections
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.
Infections
Electrostatic Architecture of the Infectious Salmon Anemia Virus (ISAV) Core Fusion Protein Illustrates a Carboxyl-Carboxylate pH Sensor.
Infections
Evaluation of a fusion gene-based DNA prime-protein boost vaccination strategy against Newcastle disease virus.
Infections
First field evidence of the evolution from a non-virulent HPR0 to a virulent HPR-deleted infectious salmon anaemia virus.
Infections
Functions of surface glycoproteins of myxoviruses and paramyxoviruses and their inhibition.
Infections
Genetic variations of IL-28B and PD-1 are in association with the susceptibility and outcomes of HCV infection in Southeast China.
Infections
Genotypic Regulation of Type I Interferon Induction Pathways by Frameshift (F) Proteins of Hepatitis C Virus.
Infections
HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
Infections
Hepatitis C virus alternate reading frame protein decreases interferon-? secretion in peripheral blood mononuclear cells.
Infections
Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesis.
Infections
Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis.
Infections
Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines.
Infections
Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
Infections
Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System.
Infections
Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.
Infections
Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Infections
Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Infections
Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Infections
Integrin ?v?1 Modulation Affects Subtype B Avian Metapneumovirus Fusion Protein-mediated Cell-Cell Fusion and Virus Infection.
Infections
Interaction of hepatitis C virus F protein with prefoldin 2 perturbs tubulin cytoskeleton organization.
Infections
Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.
Infections
Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.
Infections
Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection.
Infections
Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity.
Infections
Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion.
Infections
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.
Infections
Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis.
Infections
Morphogenesis of respiratory syncytial virus in human primary nasal ciliated epithelial cells occurs at surface membrane microdomains that are distinct from cilia.
Infections
Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies.
Infections
Persistent and lytic infections with SSPE virus: a comparison of the synthesis of virus-specific polypeptides.
Infections
Production and characterization of neutralizing monoclonal antibodies against human metapneumovirus F protein.
Infections
Prokaryotic expression of f protein from PPRV and characterization of its polyclonal antibody.
Infections
Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
Infections
Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.
Infections
Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.
Infections
Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.
Infections
Respiratory syncytial virus prolifically infects N2a neuronal cells, leading to TLR4 and nucleolin protein modulations and RSV F protein co-localization with TLR4 and nucleolin.
Infections
Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway.
Infections
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
Infections
Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem.
Infections
Role of paramyxovirus glycoproteins in the interactions between viral and cell membranes.
Infections
Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor.
Infections
Sorting signals in the measles virus wild-type glycoproteins differently influence virus spread in polarized epithelia and lymphocytes.
Infections
T helper lymphocyte response to respiratory syncytial virus and its components in patients with respiratory allergy and nonatopic controls.
Infections
TBX21 polymorphisms are associated with virus persistence in hepatitis C virus infection patients from a high-risk Chinese population.
Infections
The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
Infections
The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis.
Infections
The highest prevalence of human metapneumovirus in Ahwaz children accompanied by acute respiratory infections.
Infections
The Human Metapneumovirus Fusion Protein Mediates Entry Via an Interaction with RGD-binding Integrins.
Infections
The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV.
Infections
The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.
Infections
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
Infections
Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site.
Infections
Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
Infections
Virus-specific aNtibody, Viral Load and Disease Severity in Respiratory Syncytial Virus Infection.
Infections
[Construction and identification of replication deficient recombinant adenovirus encoding F gene of subgroup A human respiratory syncytial virus]
Infections
[Generation of recombinant vaccinia virus expressing attachment glycoprotein of Nipah virus]
Infections
[Research Progress in the F Gene and Protein of the Respiratory Syncytial Virus].
Influenza in Birds
MDV-1 VP22: a transporter that can selectively deliver proteins into cells.
Influenza, Human
A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV.
Influenza, Human
A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.
Influenza, Human
Effect of substitution of hemagglutinin-neuraminidase with influenza hemagglutinin on Sendai virus F protein mediated membrane fusion.
Influenza, Human
Evidence that TMPRSS2 activates the SARS-coronavirus spike-protein for membrane fusion and reduces viral control by the humoral immune response.
Influenza, Human
Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation.
Influenza, Human
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Influenza, Human
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.
Influenza, Human
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
Influenza, Human
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins.
Influenza, Human
The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses.
Influenza, Human
Virus membrane fusion proteins: biological machines that undergo a metamorphosis.
Intellectual Disability
In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
Liver Cirrhosis
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
Liver Diseases
Liver damage in long-term anticonvulsant therapy: a serological and histological study.
Liver Diseases
Plasma glutathione S-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damage.
Liver Neoplasms
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
Lung Diseases
Absence of Vaccine-enhanced RSV Disease and Changes in Pulmonary Dendritic Cells with Adenovirus-based RSV Vaccine.
Lung Diseases
Respiratory syncytial virus infections in infants affected by primary immunodeficiency.
Lung Diseases
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Lung Diseases, Interstitial
Experimental animal model to analyze the immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV).
Lung Diseases, Interstitial
Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant.
Lung Neoplasms
4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.
Lung Neoplasms
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Lymphatic Metastasis
The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
Lymphoma, Non-Hodgkin
Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
Measles
A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.
Measles
A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody.
Measles
A residue located at the junction of the head and stalk regions of measles virus fusion protein regulates membrane fusion by controlling conformational stability.
Measles
AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats.
Measles
Amino acid substitutions in the heptad repeat A and C regions of the F protein responsible for neurovirulence of measles virus Osaka-1 strain from a patient with subacute sclerosing panencephalitis.
Measles
Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection.
Measles
Experimental animal model to analyze the immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV).
Measles
Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo.
Measles
Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera.
Measles
Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
Measles
Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.
Measles
Inhibition of measles virus-induced cell-cell fusion with a monoclonal antibody directed against the haemagglutinin.
Measles
Measurement of polypeptide- and antigenic site-specific antibodies to measles virus using a competitive enzyme immunoassay.
Measles
Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses.
Measles
Molecular characterization of measles virus strains causing subactute sclerosing panencephalitis in France in 1977 and 2007.
Measles
Recombinant measles AIK-C strain expressing current wild-type hemagglutinin protein.
Measles
Recombinant measles virus requiring an exogenous protease for activation of infectivity.
Measles
Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression.
Measles
Reversible inhibition of the fusion activity of measles virus F protein by an engineered intersubunit disulfide bridge.
Measles
Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus.
Measles
T cell immunity to measles viral proteins in infants and adults after measles immunization.
Measles
Temperature elevation enhances cell surface expression of measles virus fusion protein in infected cells.
Measles
The DI-DII linker of human parainfluenza virus type 3 fusion protein is critical for the virus.
Measles
The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis.
Measles
The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein.
Measles
The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
Measles
The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses.
Measles
The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit.
Measles
The relative abundance of two measles virus fusion protein peptide-DR1 complexes expressed by B cells is independent of the form of the antigen.
Measles
The transmembrane domain sequence affects the structure and function of the newcastle disease virus fusion protein.
Measles
Three monoclonal antibodies against measles virus F protein cross-react with cellular stress proteins.
Measles
[The genetic characteristic analysis of fusion gene measles wild viruses of China in 2006]
Measles
[The genetic characteristics analysis of fusion gene of 13 strains measles viruses in China]
Mumps
Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function.
Mumps
Crystallization and preliminary X-ray diffraction analysis of central structure domains from mumps virus F protein.
Mumps
Effect on fusion induction of point mutations introduced into the F protein of mumps virus.
Mumps
Identification of conformational neutralization sites on the fusion protein of mumps virus.
Mumps
Identification of regions on the fusion protein of human parainfluenza virus type 2 which are required for haemagglutinin-neuraminidase proteins to promote cell fusion.
Mumps
Mumps Virus Matrix, Fusion, and Nucleocapsid Proteins Cooperate for Efficient Production of Virus-Like Particles.
Mumps
The mumps virus fusion protein mRNA sequence and homology among the paramyxoviridae proteins.
Mumps
The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit.
Mumps
[Expression and purification of heptad repeat region of the mumps virus F protein and analysis of characteristics]
Neoplasm Metastasis
Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.
Neoplasm Metastasis
Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine.
Neoplasm Metastasis
Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
Neoplasm Metastasis
Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer.
Neoplasm Metastasis
The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
Neoplasms
A preliminary estimation of tissue factor pathway inhibitor (TFPI) and protein C in patients with intracranial tumors.
Neoplasms
Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype.
Neoplasms
Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Neoplasms
Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells.
Neoplasms
Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus.
Neoplasms
Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies.
Neoplasms
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Neoplasms
Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus.
Neoplasms
Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.
Neoplasms
The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
Neoplasms
The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.
Neoplasms
The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
Neoplasms
Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen.
Neoplasms
Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.
Newcastle Disease
A host range mutant of Newcastle disease virus with an altered cleavage site for proteolytic activation of the F protein.
Newcastle Disease
A mutation in the stalk of the newcastle disease virus hemagglutinin-neuraminidase (HN) protein prevents triggering of the F protein despite allowing efficient HN-F complex formation.
Newcastle Disease
A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion.
Newcastle Disease
Acidic amino acids increase fusion activity in the specific fusion domain of Newcastle disease virus fusion protein.
Newcastle Disease
Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion.
Newcastle Disease
Alteration of immunological parameters in infectious bronchitis vaccinated-specific pathogen-free broilers after the use of different infectious bursal disease vaccines.
Newcastle Disease
Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein.
Newcastle Disease
Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies.
Newcastle Disease
Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity.
Newcastle Disease
Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10.
Newcastle Disease
Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity.
Newcastle Disease
Coordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence, and immunogenicity.
Newcastle Disease
Crystallization and preliminary X-ray diffraction analysis of post-fusion six-helix bundle core structure from Newcastle disease virus F protein.
Newcastle Disease
Decreased dependence on receptor recognition for the fusion promotion activity of L289A-mutated newcastle disease virus fusion protein correlates with a monoclonal antibody-detected conformational change.
Newcastle Disease
Design and analysis of post-fusion 6-helix bundle of heptad repeat regions from Newcastle disease virus F protein.
Newcastle Disease
Development of a double-monoclonal antibody sandwich ELISA: Tool for chicken interferon-? detection ex vivo.
Newcastle Disease
Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus.
Newcastle Disease
Expression of recombinant Newcastle disease virus F protein in Pichia pastoris and its immunogenicity using flagellin as the adjuvant.
Newcastle Disease
Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization.
Newcastle Disease
Immobilization of the N-terminal helix stabilizes prefusion paramyxovirus fusion proteins.
Newcastle Disease
Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus.
Newcastle Disease
Inhibition of Receptor Binding Stabilizes Newcastle Disease Virus HN and F Protein-Containing Complexes.
Newcastle Disease
Isolation, Identification, and Sequencing of a Goose-Derived Newcastle Disease Virus and Determination of Its Pathogenicity.
Newcastle Disease
LaSota fusion (F) cleavage motif-mediated fusion activity is affected by other regions of the F protein from different genotype Newcastle disease virus in a chimeric virus: implication for virulence attenuation.
Newcastle Disease
Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike.
Newcastle Disease
MDV-1 VP22: a transporter that can selectively deliver proteins into cells.
Newcastle Disease
Molecular characterization of two novel sub-sublineages of pigeon paramyxovirus type 1 in China.
Newcastle Disease
Mutations in the ectodomain of newcastle disease virus fusion protein confer a hemagglutinin-neuraminidase-independent phenotype.
Newcastle Disease
Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion.
Newcastle Disease
N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion.
Newcastle Disease
Newcastle disease virus f glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live-virus challenge.
Newcastle Disease
Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces.
Newcastle Disease
Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens.
Newcastle Disease
Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus.
Newcastle Disease
Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge.
Newcastle Disease
Retraction notice: LaSota fusion (F) cleavage motif-mediated fusion activity is affected by other regions of the F protein from different genotype Newcastle disease virus in a chimeric virus: implication for virulence attenuation.
Newcastle Disease
Role of the two sialic acid binding sites on the newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion.
Newcastle Disease
Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre-Lox System for Construction of a Stable Vaccine Vector.
Newcastle Disease
Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus.
Newcastle Disease
Structural features of paramyxovirus F protein required for fusion initiation.
Newcastle Disease
Structure of the Newcastle disease virus F protein in the post-fusion conformation.
Newcastle Disease
Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein.
Newcastle Disease
The 3D structure of the fusion primed Sendai F-protein determined by electron cryomicroscopy.
Newcastle Disease
The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion.
Newcastle Disease
The DI-DII linker of human parainfluenza virus type 3 fusion protein is critical for the virus.
Newcastle Disease
The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit.
Newcastle Disease
The transmembrane domain sequence affects the structure and function of the newcastle disease virus fusion protein.
Newcastle Disease
Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase protein.
Newcastle Disease
[Efficacy enhancement of a Baculovirus-vectored Newcastle Disease Virus F protein vaccine by chicken GM-CSF and IL-2].
Newcastle Disease
[Significance of paramyxovirinae protein F in physiopathology and immunity]
Paramyxoviridae Infections
A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
Paramyxoviridae Infections
Decreased dependence on receptor recognition for the fusion promotion activity of L289A-mutated newcastle disease virus fusion protein correlates with a monoclonal antibody-detected conformational change.
Paramyxoviridae Infections
Effects of multiple amino acids of the parainfluenza virus 5 fusion protein on its haemagglutinin-neuraminidase-independent fusion activity.
Paramyxoviridae Infections
Full conversion of the hemagglutinin-neuraminidase specificity of the parainfluenza virus 5 fusion protein by replacement of 21 amino acids in its head region with those of the simian virus 41 fusion protein.
Paramyxoviridae Infections
Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion.
Paramyxoviridae Infections
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.
Paramyxoviridae Infections
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses.
Paramyxoviridae Infections
Growth properties and F protein cleavage site sequences of naturally occurring human parainfluenza type 2 viruses.
Paramyxoviridae Infections
Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.
Paramyxoviridae Infections
Identification of domains on the fusion (f) protein trimer that influence the hemagglutinin-neuraminidase specificity of the f protein in mediating cell-cell fusion.
Paramyxoviridae Infections
Identification of regions on the fusion protein of human parainfluenza virus type 2 which are required for haemagglutinin-neuraminidase proteins to promote cell fusion.
Paramyxoviridae Infections
Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine.
Paramyxoviridae Infections
Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike.
Paramyxoviridae Infections
Membrane-dependent conformation, dynamics, and lipid interactions of the fusion peptide of the paramyxovirus PIV5 from solid-state NMR.
Paramyxoviridae Infections
Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2.
Paramyxoviridae Infections
Strategic priorities for respiratory syncytial virus (RSV) vaccine development.
Paramyxoviridae Infections
Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation.
Paramyxoviridae Infections
Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein.
Paramyxoviridae Infections
The aberrant gene-end transcription signal of the matrix m gene of human parainfluenza virus type 3 downregulates fusion f protein expression and the f-specific antibody response in vivo.
Paramyxoviridae Infections
The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion.
Paramyxoviridae Infections
The DI-DII linker of human parainfluenza virus type 3 fusion protein is critical for the virus.
Paramyxoviridae Infections
The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit.
Paramyxoviridae Infections
The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Paramyxoviridae Infections
Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity.
Paramyxoviridae Infections
Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus.
Paramyxoviridae Infections
Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector.
Parkinson Disease
1-Methyl-4-phenyl-pyridinium time-dependently alters expressions of oxoguanine glycosylase 1 and xeroderma pigmentosum group F protein in PC12 cells.
Peripheral Nervous System Diseases
Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.
Persistent Infection
Characterization of Sendai virus persistently infected L929 cells and Sendai virus pi strain: recombinant Sendai viruses having Mpi protein shows lower cytotoxicity and are incapable of establishing persistent infection.
Persistent Infection
Persistent and lytic infections with SSPE virus: a comparison of the synthesis of virus-specific polypeptides.
Persistent Infection
Restriction of fusion protein mRNA as a mechanism of measles virus persistence.
Persistent Vegetative State
1H, 15N, and 13C backbone chemical shift assignments, secondary structure, and magnesium-binding characteristics of the Bacillus subtilis response regulator, Spo0F, determined by heteronuclear high-resolution NMR.
Peste-des-Petits-Ruminants
Prokaryotic expression of f protein from PPRV and characterization of its polyclonal antibody.
Peste-des-Petits-Ruminants
The fusion protein of peste des petits ruminants virus is a hemolysin.
Pneumonia
Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
Pneumonia
The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion.
Prostatic Neoplasms
Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype.
Prostatic Neoplasms
Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine.
Respiratory Syncytial Virus Infections
Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection.
Respiratory Tract Infections
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
Respiratory Tract Infections
The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
Rinderpest
Fusion glycoprotein (F) of rinderpest virus: entire nucleotide sequence of the F mRNA, and several features of the F protein.
Rinderpest
Immune response and protection of cattle and pigs generated by a vaccinia virus recombinant expressing the F protein of rinderpest virus.
Rinderpest
Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.
Seizures
In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
Starvation
Tetrahymena gene encodes a protein that is homologous with the liver-specific F-antigen and associated with membranes of the Golgi apparatus and transport vesicles.
Subacute Sclerosing Panencephalitis
Alterations and diversity in the cytoplasmic tail of the fusion protein of subacute sclerosing panencephalitis virus strains isolated in Osaka, Japan.
Subacute Sclerosing Panencephalitis
Amino acid substitutions in the heptad repeat A and C regions of the F protein responsible for neurovirulence of measles virus Osaka-1 strain from a patient with subacute sclerosing panencephalitis.
Subacute Sclerosing Panencephalitis
Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.
Subacute Sclerosing Panencephalitis
Effect of the alterations in the fusion protein of measles virus isolated from brains of patients with subacute sclerosing panencephalitis on syncytium formation.
Subacute Sclerosing Panencephalitis
HN glycoprotein of HVJ (Sendai virus) enhances the selective cytotoxicity of diphtheria toxin fragment A-containing liposomes on subacute sclerosing panencephalitis virus-infected cells.
Subacute Sclerosing Panencephalitis
Measles Virus Mutants Possessing the Fusion Protein with Enhanced Fusion Activity Spread Effectively in Neuronal Cells, but Not in Other Cells, without Causing Strong Cytopathology.
Subacute Sclerosing Panencephalitis
Measurement of polypeptide- and antigenic site-specific antibodies to measles virus using a competitive enzyme immunoassay.
Subacute Sclerosing Panencephalitis
Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. IV. Nucleotide sequence of the fusion gene.
Subacute Sclerosing Panencephalitis
Molecular characterization of measles virus strains causing subactute sclerosing panencephalitis in France in 1977 and 2007.
Subacute Sclerosing Panencephalitis
Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus.
Subacute Sclerosing Panencephalitis
Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates.
Teratocarcinoma
F protein induced fusion of Sendai viral envelopes with mouse teratocarcinoma cells through Le(x)-Le(x) interaction.
Tetanus
Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
Toxic Optic Neuropathy
From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.
Triple Negative Breast Neoplasms
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Tuberculosis
Virtual screening studies to identify novel inhibitors for Sigma F protein of Mycobacterium tuberculosis.
Tyrosinemias
3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors.
Tyrosinemias
A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
Tyrosinemias
A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III.
Tyrosinemias
A novel mutation causing mild, atypical fumarylacetoacetase deficiency (Tyrosinemia type I): a case report.
Tyrosinemias
Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
Tyrosinemias
Combined 3D-quantitative structure-activity relationships and topomer technology-based molecular design of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Tyrosinemias
Hereditary tyrosinemia: metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity.
Tyrosinemias
HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage.
Tyrosinemias
Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Tyrosinemias
In vivo correction with recombinant adenovirus of 4-hydroxyphenylpyruvic acid dioxygenase deficiencies in strain III mice.
Tyrosinemias
Increased nitric oxide release by neutrophils of a patient with tyrosinemia type III.
Tyrosinemias
Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
Tyrosinemias
Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
Tyrosinemias
Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.
Tyrosinemias
Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
Tyrosinemias
Neonatal hypertyrosinemia and evidence for deficiency of ascorbic acid in Arctic and subarctic peoples.
Tyrosinemias
New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Tyrosinemias
p-Hydroxyphenylpyruvate dioxygenase is a herbicidal target site for beta-triketones from Leptospermum scoparium.
Tyrosinemias
p-hydroxyphenylpyruvate hydroxylase activity in fine-needle aspiration liver biopsies in hereditary tyrosinemia.
Tyrosinemias
Pyrazolone-quinazolone hybrids: a novel class of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Tyrosinemias
Representing and reasoning about protein families using generative and discriminative methods.
Tyrosinemias
Scavenging properties of neutrophil 4-hydroxyphenylpyruvate dioxygenase are based on a hypothesis that does not stand up to scrutiny.
Tyrosinemias
Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors.
Tyrosinemias
The discovery and structural requirements of inhibitors of p-hydroxypenylpyruvate dioxygenase.
Tyrosinemias
The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
Tyrosinemias
The Inhibitory Activity of Plants from Central Argentina on p-Hydroxyphenylpyruvate Dioxygenase. Isolation and Mechanism of Inhibition of a Flavanone from Flourensia oolepis.
Tyrosinemias
Tyrosinemia I, a model for human diseases mediated by 2-oxoacid-utilizing dioxygenases: hepatotoxin suppression by NTBC does not normalize hepatic collagen metabolism.
Tyrosinemias
Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury.
Tyrosinemias
Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
Tyrosinemias
Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS).
Vaccinia
Comparison of substrate specificities against the fusion glycoprotein of virulent Newcastle disease virus between a chick embryo fibroblast processing protease and mammalian subtilisin-like proteases.
Vaccinia
Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins.
Vaccinia
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.
Vaccinia
Immune response and protection of cattle and pigs generated by a vaccinia virus recombinant expressing the F protein of rinderpest virus.
Vaccinia
Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.
Vaccinia
Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein.
Vaccinia
Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein.
Vaccinia
Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
Vaccinia
Mechanism of reduction of virus release and cell-cell fusion in persistent canine distemper virus infection.
Vaccinia
Newcastle disease virus f glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live-virus challenge.
Vaccinia
Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2.
Vaccinia
Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.
Vaccinia
Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.
Vaccinia
Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
Vaccinia
Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus.
Vaccinia
Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.
Vaccinia
Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes.
Vaccinia
The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate.
Vaccinia
The relative abundance of two measles virus fusion protein peptide-DR1 complexes expressed by B cells is independent of the form of the antigen.
Vesicular Stomatitis
Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps.
Vesicular Stomatitis
Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins.
Vesicular Stomatitis
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production.
Vesicular Stomatitis
The surface glycoprotein E2 of bovine viral diarrhoea virus contains an intracellular localization signal.
Vesicular Stomatitis
The transmembrane domain sequence affects the structure and function of the newcastle disease virus fusion protein.
Virus Diseases
A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.
Virus Diseases
A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice.
Virus Diseases
Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.
Virus Diseases
Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus.
Virus Diseases
Characterization of the specific CD4+ T cell response against the F protein during chronic hepatitis C virus infection.
Virus Diseases
Characterization of two monoclonal antibodies, 38F10 and 44D11, against the major envelope fusion protein of Helicoverpa armigera nucleopolyhedrovirus.
Virus Diseases
Cleavage site of Newcastle disease virus determines viral fitness in persistent infection cells.
Virus Diseases
Genetic variability and circulation pattern of human metapneumovirus isolated in Italy over five epidemic seasons.
Virus Diseases
In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera.
Virus Diseases
Integrin ?v?1 Modulation Affects Subtype B Avian Metapneumovirus Fusion Protein-mediated Cell-Cell Fusion and Virus Infection.
Virus Diseases
Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection.
Virus Diseases
Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells.
Virus Diseases
Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection.
Virus Diseases
Protection of mice against Sendai virus pneumonia by non-neutralizing anti-F monoclonal antibodies.
Virus Diseases
Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium.
Virus Diseases
Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer.
Virus Diseases
The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production.
Xeroderma Pigmentosum
1-Methyl-4-phenyl-pyridinium time-dependently alters expressions of oxoguanine glycosylase 1 and xeroderma pigmentosum group F protein in PC12 cells.
Xeroderma Pigmentosum
Defining the function of xeroderma pigmentosum group F protein in psoralen interstrand cross-link-mediated DNA repair and mutagenesis.
Xeroderma Pigmentosum
Xeroderma pigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE.
html completed